Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues
Reexamination Certificate
2004-12-20
2009-10-13
Mondesi, Robert B (Department: 1645)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
C530S350000, C435S360000, C435S320100
Reexamination Certificate
active
07601799
ABSTRACT:
The present invention relates to epidermal growth factor (EGF) producing lactic acid bacteria and their use to increase intestinal villi height and to promote gut absorption. In particular, the invention relates to EGF producingLactococcus lactisandLactobacillus casei. The organisms may be especially useful to treat Short Bowel Syndrome.
REFERENCES:
patent: 4100495 (1978-07-01), Luvison et al.
patent: 4190495 (1980-02-01), Curtiss, III
patent: 4888170 (1989-12-01), Curtiss, III
patent: 5032510 (1991-07-01), Kovacevic et al.
patent: 5149532 (1992-09-01), Brunell
patent: 5240705 (1993-08-01), Jacobs
patent: 5288703 (1994-02-01), Wilmore
patent: 5330753 (1994-07-01), Mekalanos et al.
patent: 5364774 (1994-11-01), Muir et al.
patent: 5401642 (1995-03-01), Fiers et al.
patent: 5401658 (1995-03-01), Fiers et al.
patent: 5417986 (1995-05-01), Reid et al.
patent: 5455034 (1995-10-01), Nagaraja et al.
patent: 5504005 (1996-04-01), Bloom et al.
patent: 5547664 (1996-08-01), Charles et al.
patent: 5559007 (1996-09-01), Suri et al.
patent: 5591632 (1997-01-01), O'Donnell et al.
patent: 5733540 (1998-03-01), Lee
patent: 5753622 (1998-05-01), Buret et al.
patent: 5824538 (1998-10-01), Branstrom et al.
patent: 5972685 (1999-10-01), Beitz et al.
patent: 5972887 (1999-10-01), Schwartz
patent: 6130082 (2000-10-01), Majarian et al.
patent: 6190662 (2001-02-01), Steidler et al.
patent: 6190669 (2001-02-01), Noriega et al.
patent: 6221648 (2001-04-01), Le Page et al.
patent: 6261561 (2001-07-01), Stewart et al.
patent: 6605286 (2003-08-01), Steidler
patent: 6656907 (2003-12-01), Buret et al.
patent: 6746671 (2004-06-01), Steidler et al.
patent: 2001/0006642 (2001-07-01), Steidler et al.
patent: 2004/0043003 (2004-03-01), Chen et al.
patent: 42 31 764 (1994-03-01), None
patent: 0 176 320 (1986-04-01), None
patent: 0 406 003 (1991-01-01), None
patent: 0 449 770 (1991-10-01), None
patent: 0 450 176 (1991-10-01), None
patent: 1 092 437 (2001-04-01), None
patent: 1 319 410 (2003-06-01), None
patent: 2278358 (1994-11-01), None
patent: WO 97/14806 (1997-04-01), None
patent: WO 88/06626 (1988-09-01), None
patent: WO 90/00594 (1990-01-01), None
patent: WO 91/06654 (1991-05-01), None
patent: WO 93/17117 (1993-09-01), None
patent: WO 95/03418 (1995-02-01), None
patent: WO 95/10614 (1995-04-01), None
patent: WO 95/10621 (1995-04-01), None
patent: WO 96/11277 (1996-04-01), None
patent: WO 96/40947 (1996-12-01), None
patent: WO 97/14806 (1997-04-01), None
patent: WO 98/31786 (1998-07-01), None
patent: WO 99/58652 (1999-11-01), None
patent: WO 00/01799 (2000-01-01), None
patent: WO 00/18377 (2000-04-01), None
patent: WO 00/22909 (2000-04-01), None
patent: WO 00/23471 (2000-04-01), None
patent: WO 02/0090551 (2002-11-01), None
patent: WO 2004-001020 (2003-12-01), None
patent: WO 2004/046346 (2004-06-01), None
Sham et al (Epidermal Growth Factor Improves Nutritional Outcome in a Rat Model of Short Bowel Syndrome, Journal of Pediatric Surgery, 2002; 37(5): 765-769).
Wells, et al (Lactic acid bacteria as vaccine delivery vehicles, Antonie van Leeuwenhock, 1996; 70:17-330).
Elliott et al (Bacterial colonization and healing of gastric ulcers: the effects of epidermal growth factor, Am. J. Physiol. Gastrointest. Liver Physiol., 2000; 278:G105-G112).
Eizaguirre et al (Effect of Growth Hormone, Epidermal Growth Factor, and Insulin on Bacterial Translocation in Experimental Short Bowel Syndrome, Journal of Pediatric Surgery, 2000; 35(5): 692-695).
Wells et al (Lactic acid bacteria as vaccine delivery vehicles, Antonie van Leuwenhock, 1996; 70: 317-330).
Sham et (Epidermal Growth Factor Improves Nutritional Outcome in a Rat Model of Short Bowel Syndrome, Journal of Pediatric Surgery, 2002; 37(5): 765-769).
Hardin et al. (Gut, 1999; 44: 26-32).
Stern et al. (Microscopy Research and Technique, 2000; 51: 138-148).
Elliott et al., Bacterial colonization and healing of gastric ulcers: the effects of epidermal growth factor, Am J. Physiol. Gastrointest. Liver Physiol., 2000, pp. G105-G112, vol. 278.
PCT International Search Report, PCT/EP03/50242, dated Jan. 15, 2004.
Wells et al., Lactic acid bacteria as vaccine delivery vehicles, Antonie van Leeuwenhoek, 1996, pp. 317-330, vol. 70, No. 2-4, Kluwer Academic Publishers, the Netherlands.
Kurahayashi et al., Effects of EGF administration in the intestinal adaptation in the rat after massive intestinal resection, Diagnostics and New Medicaments, 1991, pp. 1691-1701, vol. 28, No. 9. Abstract only.
Bamba et al., Gastroentorol Jpn., 1993, pp. 511-517, vol. 28, No. 4.
Rao et al., Eur. J. Pharmacol., 1996, pp. 209-12, vol. 303, No. 3.
English translation of the Japanese Office Action dated Apr. 7, 2009.
U.S. Appl. No. 60/353,923, filed Jan. 31, 2002, Chen.
U.S. Appl. No. 60/353,964, filed Jan. 31, 2002, Chen.
U.S. Appl. No. 60/353,885, filed Jan. 31, 2002, Chen.
U.S. Appl. No. 60/401,465, filed Aug. 5, 2002, Chen.
Arslanoglu et al., 1998, Biotechnology Letters, pp. 917-921, vol. 20.
Boersma et al., (1995) “Lactobacillus as vectors with intrinsic adjuvanticity for safe live mucosal vaccines,” Biochemistry Supplement 19A, p. 255.
Bojovic et al., Applied & Environ. Microbiol., 57/2:385-388(1991).
Brett et al., Eur. J. Immunol., 23:1608-1614 (1993).
Edwards et al., Infection & Immunity, 60/6:2514-2521 (1992).
Fu et al., Abstract “Development of a chromosome-plasmid balanced lethal system for Lactobacillus acidophilus with thyA gene as selective marker,” Microbiol. Immunol., 2000, pp. 551-556, vol. 44, No. 7.
Gasson, Abstract, “In vivo genetic systems in lactic acid bacteria,” FEMS Microbiol., 1990, Rev. 87:43-60.
Heath et al., Abstract. Cytokines as immunological adjuvants, Vaccine, 1992, pp. 427-34, vol. 10, No. 7.
Holmes et al., Infection & Immunity, 66/10:4633-4639 (1998).
Iwaki et al., Infection Immunity, 58/9:2929-2934 (1990).
Koivula et al., Isolation and Characterization of Lactococcus lactis subsp. lactis Promoters, Applied and Environmental Microbiology, Feb. 1991, pp. 333-340, vol. 57, No. 2.
Kong et al.. Secretion of Human Interleukin 2 by Recombinant Mycobacterium bovis BCG, Infection and Immunity, Mar. 1995. pp. 799-803. vol. 63, No. 3.
Leong et al., Selective Induction of Immune Responses by Cytokines Coexpressed in Recombinant Fowlpox Virus, Journal of Virology, Dec. 1994, pp. 8125-8130. vol. 68, No. 12.
Leong-Morgenthaler et al., Lactose Metabolism in Lactobacillus bulgaricus: Analysis of the Primary Structure and Expression of the Genes Involved, Journal of Bacteriology, Mar. 1991, pp. 1951-57. vol. 173. No. 6.
Norton et al., Fems Immunol. & Medical Nicrobiol. 14:167-177 (1996).
Norton et al., Fems Microbiol. Letters, 120:249-256 (1994).
Norton et al., Vaccine, 15/6-7:616-619 (1997).
Norton, (1995) “Progress in the Development of Lactococcus lactis as a Recombinant Mucosal Vaccine Delivery System,” Folia Microbiol. 40:225-230.
PCT International Preliminary Examination Report, PCT/EP03/50832, dated Jul. 6, 2004.
PCT International Search Report, PCT/EP2005/052296, dated Sep. 5, 2005.
Rapoport, Current Opinion in Biotechnology, 1:21-27 (1990).
Robinson et al., Nature Biotechnology, 15:653-57 (1997).
Ross et al., Cloning and Characterization of the Thymidylate Synthase Gene from Lactococcus lactis subsp. lactis, Applied and Environmental Microbiology, Jul. 1990, pp. 2156-2163, vol. 56, No. 7.
Ross et al., Thymidylate Synthase Gene from Lactococcus lactis as a Genetic Marker: an Alternative to Antibiotic Resistance Genes, Applied and Environmental Microbiology, Jul. 1990, pp. 2164-2169, vol. 56. No. 7.
Salzet, Michel, “Leech Thrombin Inhibitors,” Current Pharmacuetical Design, 2002, pp. 493-503, vol. 8.
Sasaki et al., “thyA as a Selection Marker in Construction of Food-Grade Host-Vector and Integration Systems for Streptococcus thermophilus,” Applied and Environmental Microbiology, Mar. 2004, pp. 1858-1864, vol. 70, No. 3.
Schotte et al., Secretion of biologically active murine interleukin-10 by Lactococcus lactis, Enzyme and Microbial Technology, 2000, pp. 761-65. vol. 27.
S
Actogenix N.V.
Mondesi Robert B
Tongue Lakia J
TraskBritt
LandOfFree
Methods and means to promote gut absorption does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and means to promote gut absorption, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and means to promote gut absorption will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4115933